Phase IV cancer treatment, often referred to as the post-marketing phase, occurs after a new cancer therapy has been approved and made available to the public. In this phase, the primary goal is to monitor the long-term efficacy and safety of the treatment in a larger and more diverse patient population. This phase is crucial for identifying rare or long-term side effects and for gathering additional information that can guide future treatment protocols.
